about
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study.Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseasesAcetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strainsEarly postnatal overfeeding induces early chronic renal dysfunction in adult male rats.Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers.Extracellular Vesicles in Angiogenesis.Endothelial Progenitors: A Consensus Statement on NomenclatureFibrinolytic cross-talk: a new mechanism for plasmin formation.Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression.Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin.The cardiovascular effect of the uremic solute indole-3 acetic acid.P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in miceAntibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific AntibodiesSoluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.Physico-chemical factors influencing autologous conditioned serum purification.Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis.Revisited role of microparticles in arterial and venous thrombosis.Involvement of neutrophils in thrombus formation in living mice.The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells.Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes.Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention.Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences.Microparticles and cancer thrombosis in animal models.Pleiotropic effects of ticagrelor: Myth or reality?Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients.Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter?Microparticles and Fibrinolysis.Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment.Methodological Guidelines to Study Extracellular Vesicles.Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop.Histological and Urodynamic Effects of Autologous Stromal Vascular Fraction Extracted from Fat Tissue with Minimal Ex Vivo Manipulation in a Porcine Model of Intrinsic Sphincter Deficiency.Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.Biogenesis of Pro-senescent Microparticles by Endothelial Colony Forming Cells from Premature Neonates is driven by SIRT1-Dependent Epigenetic Regulation of MKK6.Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect.Gestational age-related patterns of AMOT methylation are revealed in preterm infant endothelial progenitors.Level of adenosine diphosphate receptor P2Y12 blockade during percutaneous coronary intervention predicts the extent of endothelial injury, assessed by circulating endothelial cell measurement.Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats.
P50
Q33416860-1B604841-752F-4C1A-8EBE-1728363DEEAFQ33417775-A33F0786-60BF-4780-AF2F-4D8A91EE013CQ33443707-0E139C0E-2F58-4D99-893F-8F8836830874Q33490903-D38F18F4-0848-485E-8E4D-01E3F1D8C19CQ33578948-183AB1FD-2A23-4F59-B6E8-FBC1A8803CD5Q33663907-CEBD54C6-E9BE-4234-9F0D-247DB931D8A4Q33722081-F6C5FCE5-512C-4DC4-9D30-3A14F56FF388Q33959551-30E106D5-C2A5-415F-9556-1DBACFF13384Q34403678-2481DF78-EEBE-4129-8A9B-258D6403630EQ35113822-5C8BA2C6-A510-4D05-A356-6C649E0679DAQ35228517-83B6158E-7104-4B23-8DB9-96A010A059D8Q35230316-C8225DCD-4233-465E-9452-CD0BC3C7ED95Q36113914-E6526E79-3D7B-4661-834C-CBB0E7ED9F86Q36307573-E46B0BD2-E628-4356-8392-38A8A5D5B77AQ36772138-C0E4122F-37E2-4497-80DF-3605D2FD63A4Q37592880-9234492C-2621-4FA8-A9F8-BB31E51C8C39Q37713525-A04F8469-BED0-422E-AE75-E0BDA627C6E6Q38117725-2C1FC941-2D80-404D-B079-5F0E201337A9Q38184163-608FDF15-289F-4740-B4D7-57B15765537EQ38319415-8741B66D-F7BC-4D63-A37D-CA416F061C32Q38437197-E7F5D54B-F149-4898-95F7-E22129B75797Q38437993-9AB5FCCE-A50E-4C1E-9703-50BF6F722D3CQ38750593-A3A4C699-1A23-4257-B2EA-4855BF7D164CQ38805409-77B76084-6AE2-4632-87A6-92A4DB751B38Q38876413-FC56536F-D1E6-4054-904E-C79012B7F8D2Q38878106-60F44169-69A7-4361-B47E-523DF70A494BQ39008328-982088B7-20E8-43FA-A410-840F801F83E7Q39030810-F2AA397E-1C74-4088-ABB7-B210D66F90D6Q39132672-95991AB4-67E8-417B-A462-2EAB9F66569BQ39299869-476ACDF1-B76D-45CA-A634-8D7ED5C022AEQ39590400-C8105A92-8541-4E43-B28B-BDE99DC7E37AQ39707911-359086D2-7574-4618-87E7-B73B4E393E9DQ40534218-483E34C7-89E0-4F13-8BC9-458706FFF2EBQ40658695-0B7E67F5-4FA3-420B-B868-755B46E6C400Q41422353-7B164C1F-4CC2-4C00-A1FD-4661780423F5Q41811602-21F7CBB2-C52E-40B4-BE57-B39D0190FC29Q42696297-7309C0BE-279D-420B-B14E-EAD36B1FFE6BQ42905599-68430C48-001D-43E2-B6C3-5BAAF82A08FAQ43873602-F4AA19EC-A2CE-421F-B2AB-1C613A9E3B69Q44045737-DD35D35D-E01C-4B42-956F-C6A6DEEDB6E1
P50
description
forsker
@nb
researcher ORCID ID = 0000-0001-7006-4462
@en
wetenschapper
@nl
name
F. DIGNAT-GEORGE
@ast
F. DIGNAT-GEORGE
@nl
Françoise Dignat-George
@en
Françoise Dignat-George
@nb
type
label
F. DIGNAT-GEORGE
@ast
F. DIGNAT-GEORGE
@nl
Françoise Dignat-George
@en
Françoise Dignat-George
@nb
altLabel
F. DIGNAT-GEORGE
@en
prefLabel
F. DIGNAT-GEORGE
@ast
F. DIGNAT-GEORGE
@nl
Françoise Dignat-George
@en
Françoise Dignat-George
@nb
P108
P31
P496
0000-0001-7006-4462